Exscientia is a global pharmatech company using patient-first artificial intelligence (AI) to discover better drugs, faster.
Our mission is to encode, automate and transform every stage of the drug design and development process, by combining the latest AI techniques with experimental innovation, to enable the design of patient centric drug candidates with an improved probability of success.
Our validated platform has delivered the first three AI-designed drugs to enter clinical trials and is the first AI system proven to improve clinical outcomes in oncology. We’ve significantly accelerated pre-clinical drug discovery, with 10x productivity improvement in delivering a drug candidate compared with industry standards.
By actively applying AI to precision engineer medicines more rapidly and efficiently, we allow the best ideas of science to rapidly become the best medicines for patients.
Location: United Kingdom, England, Oxford
Employees: 201-500
Total raised: $689.2M
Founded date: 2012
Investors 3
Date | Name | Website |
- | Frontier I... | frontierip... |
15.10.2021 | Air Street... | airstreet.... |
- | NFLS - Piv... | pivotalbio... |
Funding Rounds 4
Date | Series | Amount | Investors |
27.04.2021 | - | $525M | - |
04.03.2021 | Series C | $100M | - |
15.01.2021 | Grant | $4.2M | - |
26.05.2020 | - | $60M | - |
Mentions in press and media 30
Date | Title | Description | Source |
01.02.2024 | Salary data revealed: Here's how much 16 top US and European... | Premium Tech Salary data revealed: Here's how much 16 top US and European AI startups like OpenAI, A... | businessin... |
15.09.2023 | Первобытный страх перед нейросетями или круги на воде... | Содержание статьи: 1. Вступление 2. Краткий обзор некоторых нейросетевых технологий, появившихся за ... | habr.com/r... |
06.09.2023 | Air Street Capital's $121M Fund II backed by Spotify founder... | London-based VC Air Street Capital has announced its $121 million Fund II to back AI-first early-sta... | tech.eu/20... |
22.05.2023 | Exscientia Highlights “The Future of AI-enabled Drug Discove... | Exscientia plc announced two abstracts for oral and poster presentation, as well as the closing keyn... | aithority.... |
15.05.2023 | Exscientia Announces Sixth Molecule Created Through Generati... | Exscientia plc announced that Sumitomo Pharma Co., Ltd. (‘Sumitomo Pharma’) plans to initiate a Phas... | aithority.... |
14.11.2022 | Exscientia and MD Anderson Launch Strategic Collaboration to... | Effort aligns MD Anderson’s drug development expertise with Exscientia’s AI-driven patient-first pre... | aithority.... |
31.08.2022 | Exscientia expands AI-powered drug discovery in Miami | Facebook Tweet Pin LinkedIn Email By Riley Kaminer In the future, all drugs will be discovered using... | refreshmia... |
07.01.2022 | Exscientia and Sanofi establish strategic research collabora... | Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of pr... | globenewsw... |
27.12.2021 | DIGIT’s Biggest Scottish Deals of 2021 | Despite a difficult two years due to the pandemic and the impact of Brexit, Scottish companies have ... | digit.fyi/... |
14.06.2021 | AI drug discovery startup latest to go public via $2.8B SPAC... | AI drug discovery startup Valo announced it’s going public via a $2.8 billion SPAC merger with Khosl... | emarketer.... |
Show more